Innospec Balance Sheet
NASDAQ: IOSPIndustrialsMajor ChemicalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Innospec financial position
At the end of fiscal 2025, Innospec reported total assets of $1.83 billion, up 5.6% from a year earlier against total liabilities of $499.5 million. Shareholders' equity stood at $1.33 billion, or 72.4% of assets. The company held $292.5 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 2.79, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Innospec balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 292.50M | 289.20M | 203.70M | 147.10M | 141.80M | 105.30M | 75.70M | 123.10M | 90.20M | 101.90M |
| Short-Term Investments | — | — | — | — | — | — | — | — | — | 0 |
| Receivables | 342.30M | 341.70M | 359.80M | 334.60M | 284.50M | 221.40M | 292.00M | 279.70M | 244.50M | 154.40M |
| Inventory | 329.30M | 301.00M | 300.10M | 373.10M | 277.60M | 220.00M | 244.60M | 248.00M | 209.80M | 173.80M |
| Total Current Assets | 1.00B | 956.60M | 885.70M | 872.60M | 728.10M | 566.20M | 630.30M | 663.90M | 561.50M | 441.10M |
| Property, Plant & Equipment | 286.10M | 269.70M | 268.30M | 220.90M | 214.40M | 210.80M | 198.70M | 196.40M | 196.00M | 157.40M |
| Goodwill | 399.00M | 382.50M | 399.30M | 358.80M | 364.30M | 371.20M | 363.00M | 364.90M | 361.80M | 374.80M |
| Intangible Assets | 67.70M | 65.40M | 57.30M | 45.00M | 57.50M | 75.30M | 113.50M | 136.30M | 163.30M | 144.40M |
| Total Assets | 1.83B | 1.73B | 1.71B | 1.60B | 1.57B | 1.40B | 1.47B | 1.47B | 1.41B | 1.18B |
| Accounts Payable | 174.70M | 163.80M | 163.60M | 165.30M | 148.70M | 98.70M | 122.00M | 126.80M | 117.90M | 59.60M |
| Short-Term Debt | — | — | — | — | — | 0 | 0 | 21.40M | 15.80M | 10.30M |
| Total Current Liabilities | 360.10M | 371.40M | 371.50M | 405.80M | 336.60M | 252.40M | 303.50M | 296.60M | 261.50M | 183.10M |
| Long-Term Debt | — | — | — | — | — | 0 | 58.60M | 186.20M | 202.60M | 258.50M |
| Total Liabilities | 499.50M | 518.60M | 557.80M | 563.30M | 537.90M | 452.50M | 549.90M | 647.90M | 615.90M | 527.60M |
| Shareholders' Equity | 1.33B | 1.21B | 1.15B | 1.04B | 1.03B | 944.40M | -74.40M | 825.00M | 793.90M | 653.50M |
| Retained Earnings | 1.10B | 1.02B | 1.03B | 924.20M | 822.90M | 758.60M | 755.50M | 668.30M | 605.00M | 561.80M |
| Total Debt | — | — | — | — | — | 0 | 58.60M | 207.60M | 218.40M | 268.80M |
| Net Cash (Debt) | 292.50M | 289.20M | 203.70M | 147.10M | 141.80M | 105.30M | 17.10M | -84.50M | -128.20M | -166.90M |
This table shows 10 annual periods of Innospec's balance sheet, from FY 2025 back to FY 2016, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow IOSP's reporting calendar. What is a balance sheet?